Basu S - Search Results

1

High-Specific-Activity-¹³¹I-MIBG versus ¹⁷⁷Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.

Jha A, Taïeb D, Carrasquillo JA, Pryma DA, Patel M, Millo C, de Herder WW, Del Rivero J, Crona J, Shulkin BL, Virgolini I, Chen AP, Mittal BR, Basu S, Dillon JS, Hope TA, Mari Aparici C, Iagaru AH, Hicks RJ, Avram AM, Strosberg JR, Civelek AC, Lin FI, Pandit-Taskar N, Pacak K. Jha A, et al. Among authors: basu s. Clin Cancer Res. 2021 Jun 1;27(11):2989-2995. doi: 10.1158/1078-0432.CCR-20-3703. Epub 2021 Mar 8. Clin Cancer Res. 2021. PMID: 33685867 Free PMC article. Review.

2

Stable disease and improved health-related quality of life (HRQoL) following fractionated low dose 131I-metaiodobenzylguanidine (MIBG) therapy in metastatic paediatric paraganglioma: observation on false "reverse" discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapy.

Basu S, Nair N. Basu S, et al. Br J Radiol. 2006 Aug;79(944):e53-8. doi: 10.1259/bjr/27645093. Br J Radiol. 2006. PMID: 16861319

3

PET and PET-CT imaging in infection and inflammation: its critical role in assessing complications related to therapeutic interventions in patients with cancer.

Basu S, Kumar R, Alavi A. Basu S, et al. Indian J Cancer. 2010 Oct-Dec;47(4):371-9. doi: 10.4103/0019-509X.73562. Indian J Cancer. 2010. PMID: 21131748 Free article. Review.

4

Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.

Jois B, Asopa R, Basu S. Jois B, et al. Among authors: basu s. Clin Nucl Med. 2014 Jun;39(6):505-10. doi: 10.1097/RLU.0000000000000429. Clin Nucl Med. 2014. PMID: 24662668

5

The use of 99mTc-HYNIC-TOC and 18F-FDG PET/CT in the evaluation of duodenal neuroendocrine tumor with atypical and extensive metastasis responding dramatically to a single fraction of PRRT with 177Lu-DOTATATE.

Basu S, Abhyankar A. Basu S, et al. J Nucl Med Technol. 2014 Dec;42(4):296-8. doi: 10.2967/jnmt.114.139238. Epub 2014 Sep 4. J Nucl Med Technol. 2014. PMID: 25190735 Free article.

6

Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practice.

Abhyankar A, Basu S. Abhyankar A, et al. Among authors: basu s. J Cancer Res Ther. 2015 Jul-Sep;11(3):648. doi: 10.4103/0973-1482.143360. J Cancer Res Ther. 2015. PMID: 26458613 Free article.

7

Favorable Response of Metastatic Merkel Cell Carcinoma to Targeted 177Lu-DOTATATE Therapy: Will PRRT Evolve to Become an Important Approach in Receptor-Positive Cases?

Basu S, Ranade R. Basu S, et al. J Nucl Med Technol. 2016 Jun;44(2):85-7. doi: 10.2967/jnmt.115.163527. Epub 2015 Oct 15. J Nucl Med Technol. 2016. PMID: 26471333 Free article. Review.

8

177Lu-DOTATATE versus 177Lu-EDTMP versus cocktail/sequential therapy in bone-confined painful metastatic disease in medullary carcinoma of the thyroid and neuroendocrine tumour: can semiquantitative comparison of 68Ga-DOTATATE and 18F-fluoride PET-CT aid in personalized treatment decision making in selecting the best therapeutic option?

Basu S, Ranade R, Thapa P. Basu S, et al. Nucl Med Commun. 2016 Jan;37(1):100-2. doi: 10.1097/MNM.0000000000000397. Nucl Med Commun. 2016. PMID: 26587985 No abstract available.

9

Discordant and aggressive tumor biology of solitary scalp metastasis amidst widespread skeletal metastases in differentiated thyroid carcinoma: Functional radionuclide and MR imaging features and clinical correlates.

Basu S, Mahajan A. Basu S, et al. Indian J Cancer. 2014 Oct-Dec;51(4):613-4. doi: 10.4103/0019-509X.175309. Indian J Cancer. 2014. PMID: 26842213 Free article. No abstract available.

10

177Lu-DOTATATE PRRT in Patients with Metastatic Neuroendocrine Tumor and a Single Functioning Kidney: Tolerability and Effect on Renal Function.

Ranade R, Basu S. Ranade R, et al. Among authors: basu s. J Nucl Med Technol. 2016 Jun;44(2):65-9. doi: 10.2967/jnmt.115.168146. Epub 2016 Feb 4. J Nucl Med Technol. 2016. PMID: 26848166 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,490 results

Search Page